Objectives: We investigated the financial impact of different prevalence levels of severe tail lesions (STL) during the finisher stage associated with changes in average daily gain (ADG) in farrow-to-finish pig farms.
Methods: Prevalence of STL was estimated for 31 farrow-to-finish pig farms. Regression tree analysis was used to identify a threshold for STL associated with differences in ADG. Then, a financial analysis was carried using the Teagasc Pig Production model.
Results: A threshold of ≥0.86% prevalence of STL was associated with a 4.8% decrease in ADG which translated into pigs requiring 7 days more to reach target slaughter weight than in farms below the threshold. Reduced ADG meant that farms with higher prevalence of STL used 3.6% more weaner and 1.4% more finisher feed per year increasing feed costs by 1.5%. This reduced mean annual farm profit by 15.1% in farms with higher prevalence of STL.
Conclusions: Our results provide an indication of the financial effects of STL in intensive pig production systems. The identified threshold for the prevalence of STL could provide a tangible target for farmers to focus on in developing strategies to reduce tail lesions and allow farmers to complete a cost benefit analysis of controlling STL.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/vetr.13 | DOI Listing |
BMC Oral Health
November 2024
Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Erlangen of Friedrich-Alexander University Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.
Background: In order to successfully perform orthodontic mini-implant procedures successfully for the subsequent anchoring of orthodontic appliances, it is crucial to know the palatal bone thickness. This is usually assessed using two-dimensional radiographs. The purpose of this study was to use a three-dimensional digital imaging measurement method to provide information on palatal bone volume and bone thickness and to make recommendations on the optimal and safe insertion site and angle for palatal mini-implants.
View Article and Find Full Text PDFInfluenza Other Respir Viruses
November 2024
Department of Organization and Management in Health Care, Poznan University of Medical Sciences, Poznań, Poland.
Objective: The aim of the study is to analyze the annual cycle of pediatric medically attended respiratory illnesses.
Study Design: Data on 141 million pediatric respiratory visits from the years 2010-2019 were obtained from the Polish National Healthcare Fund. To identify underlying patterns and trends within the aggregated data, techniques like seasonal-trend decomposition using LOESS (STL) and principal component analysis (PCA) were applied.
Diabet Med
October 2024
Centre for Public Health, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, UK.
Aim: Diabetes is increasing in prevalence worldwide, with a 20% rise in prevalence predicted between 2021 and 2030, bringing an increased burden of complications, such as diabetic kidney disease (DKD). DKD is a leading cause of end-stage kidney disease, with significant impacts on patients, families and healthcare providers. DKD often goes undetected until later stages, due to asymptomatic disease, non-standard presentation or progression, and sub-optimal screening tools and/or provision.
View Article and Find Full Text PDFSci Rep
October 2024
College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, 601 Jin Sui Avenue, Xinxiang, China.
Pilocytic astrocytoma (PA) is classified as a Grade I benign neuroglial tumor. The extent of surgical resection is a critical factor influencing the prognosis for patients with PA. In prior researches of PA, the extent of surgical resection is generally categorized into GTR, STR and biopsy.
View Article and Find Full Text PDFRadiology
September 2024
From the Departments of Surgery, Colorectal Service (H.W., D.M.O., H.M.T., F.S.V., J.B.Y., J.B., M.R.M., J.G.A.), Epidemiology and Biostatistics (S.T.L., L.X.Q.), and Radiology (J.M., M.J.G.), Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065; Department of Radiology, University of Rochester Medical Center, Rochester, NY (D.A.D.); Department of Radiology, University of South Florida, Tampa, Fla (R.K.); Department of Radiology, University of Chicago, Chicago, Ill (A.O.); Department of Radiology, Oregon Health and Science University, Portland, Ore (E.K.); Department of Radiology, Cleveland Clinic, Cleveland, Ohio (J.C.V.); Department of Radiology, John Muir Health, Walnut Creek, Calif (S.G.); Department of Radiology, University of Virginia, Charlottesville, Va (A.K.); Department of Radiology, University of Washington, Seattle, Wash (M.J.); Department of Radiology, St Joseph Hospital Orange County, Orange, Calif (K.O., D.V.); Department of Radiology, University of California San Francisco, San Francisco, Calif (T.A.H.); Department of Radiology, University of California Irvine, Irvine, Calif (S.L.); Department of Radiology, University of Michigan, Ann Arbor, Mich (A.P.W.); and Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colo (N.M.).
Background MRI plays a crucial role in restaging locally advanced rectal cancer treated with total neoadjuvant therapy (TNT); however, prospective studies have not evaluated its ability to accurately select patients for nonoperative management. Purpose To evaluate the ability of restaging MRI to predict oncologic outcomes and identify imaging features associated with residual disease (RD) after TNT. Materials and Methods This was a secondary analysis of the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial, which randomized participants from April 2014 to March 2020 with stages II or III rectal adenocarcinoma to undergo either induction or consolidation TNT.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!